Kimberly-Clark to acquire Tylenol's parent company in nearly $49B deal

Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?

Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...

Kimberly-Clark Strikes $40 Billion Deal for Tylenol Maker Kenvue

The agreement, which combines the maker of Huggies diapers with the owner of the painkiller brand, will create a global ...
The Daily Caller on MSN

Massive Conglomerate Gobbles Up Tylenol Maker In $48.7 Billion Mega-Deal

Kimberly-Clark announced Monday that it will buy Kenvue for around $48.7 billion, uniting the Huggies diaper maker with the ...

Kimberly-Clark, parent company of Kleenex and Huggies, buys the maker of Tylenol in $48.7 billion deal. What you need to know

Kimberly-Clark, which owns Huggies and Kleenex, is acquiring Kenvue, the maker of Tylenol, in a cash and stock deal worth ...

Catching Covid-19 During Pregnancy Could Raise Autism Risk in Children, Study Finds

Researchers pinpointed an association between maternal covid-19 infections and children being diagnosed with ...